2Ksiazek TG,Rollin PE,Williams AJ,et al.Clinical virology of Ebola hemorrhagic fever (EHF):virus,virus antigen,and IgG and IgM antibaby findings among EHF patients in Kikwit,Democratic Republic of the Congo,1995.J Infect Dis,1999,1:177-187.
2Takada, A, Watanabe S, Ito H, et al. Downregulation of beta 1 integrins by Ebola virus glycoprotein: implication for virus entry[J]. Virology, 2000,278 (1):20-26.
4Walsh PD, Abemethy KA, Bermejo M, et al. Catastrophic ape decline in western equatorial Africa [J]. Nature, 2003,422 (6 932): 611 - 614.
5Wilson JA, Bosto CM, Hart MK. Ebola virus: the search for vaccines and treatments [ J]. Cell Mol Life Sci, 2001,58 (12/13):1 826- 1 841.
6Xu L, Sanchez A, Yang Z, et al. Immunization for Ebola virus infection[J].Nat Med, 1998, 4 (1): 37-42.
7Yang, ZY, Duckers HJ, Sullivan NJ, etal. Identification of the Ebola virus glycoprotein as the main viral determinant of vasular cell cytotoxicity and injury [ J ]. Nat Med, 2000,6 (8) :886- 889.
8Volchkov , VE , Volchkova VA , Muhlberger E , et al .Recovery of infectious Ebola virus from complementary DNA:RNA editing of the GP gene and viral cytotoxicity [ J ].Science, 2001, 291 (5 510): 1 965 - 1 969.
9Chan SY, Ma MC, Goldsmith MA. Differentia induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses [J]. J Gen Virol, 2000, 81 (Pt 9):2 155- 2 159.
10Reiter P, M Turell, R Coleman, et al. Field investigation of an outbreak of ebola hemorrhagic fever,Kikwit, Democratic Republic of the Congo, 1995:Arthropod studies[J]. J Inf Dis, 1999, 179:s148.
